BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 1825244)

  • 1. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
    Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Stenzel KH; Rubin AL
    Transplantation; 1991 Feb; 51(2):378-81. PubMed ID: 1825244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of donor-specific immune modulation and successful renal transplantation with a simplified method of donor-specific blood transfusion.
    Cheigh JS; Suthanthiran M; Fotino M; Kaplan M; Evelyn M; Schechter N; Wolf CF; Riggio RR; Riehle R; Stubenbord WT
    Uremia Invest; 1985-1986; 9(1):11-7. PubMed ID: 2940741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of donor specific blood transfusion in kidney transplantation.
    Cheigh JS; Suthanthiran M; Stubenbord WT; Fotino M; Riggio RR; Schechter N; Stenzel KH; Rubin AL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2250-1. PubMed ID: 2978891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of preoperative donor-specific transfusion and cyclosporine in haplo-identical living related renal transplant recipients.
    Sharma RK; Rai PK; Kumar A; Kumar P; Gupta A; Kher V; Agrawal S; Bhandari M
    Nephron; 1997; 75(1):20-4. PubMed ID: 9031265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of donor specific blood transfusion (DST) on graft survival--intermittent coverage of cyclophosphamide].
    Kasai I; Kumano K; Iwamura M; Yoshida K; Mashimo S; Endo T; Saaki T; Koshiba K; Kikuo I; Uchida H
    Nihon Hinyokika Gakkai Zasshi; 1990 Mar; 81(3):367-71. PubMed ID: 2359213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of donor-specific blood transfusion on the outcome of kidney transplantation].
    Jovicić-Pavlović S; Lezaić V; Simić S; Blagojević-Lazić R; Stolić I; Simonović R; Radivojević-Djokić D; Djukanović L
    Srp Arh Celok Lek; 2003; 131(11-12):449-53. PubMed ID: 15114786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term graft survival with or without donor-specific transfusion in cyclosporine era in one haplo-identical living-related renal transplant recipients beyond the first year: a 19-year experience.
    Satoh S; Sugimura J; Omori S; Seino K; Fujizuka I
    Tohoku J Exp Med; 2002 Aug; 197(4):201-7. PubMed ID: 12434995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacy.
    Salvatierra O; Melzer J; Potter D; Garovoy M; Vincenti F; Amend WJ; Husing R; Hopper S; Feduska NJ
    Transplantation; 1985 Dec; 40(6):654-9. PubMed ID: 3907038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
    Barber WH; Hudson SL; Deierhoi MH; Laskow DA; Gaston RS; Julian BA; Curtis JJ; Diethelm AG
    Clin Transpl; 1990; ():289-300. PubMed ID: 2103152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-specific transfusion: a report of the Japanese Renal Transplant Registry.
    Sonoda T; Ishibashi M
    Clin Transpl; 1987; ():257-60. PubMed ID: 2978999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ultraviolet-B-irradiated donor-specific blood transfusions and peritransplant immunosuppression with cyclosporine on rat cardiac allograft survival.
    Oluwole SF; Lau HT; Reemtsma K; Hardy MA
    Transplantation; 1988 Feb; 45(2):293-7. PubMed ID: 3278417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man.
    Lazda VA; Pollak R; Mozes MF; Barber PL; Jonasson O
    Transplantation; 1990 Jun; 49(6):1084-7. PubMed ID: 2360251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
    Flye MW; Burton K; Mohanakumar T; Brennan D; Keller C; Goss JA; Sicard GA; Anderson CB
    Transplantation; 1995 Dec; 60(12):1395-401. PubMed ID: 8545863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant conditioning with donor-specific transfusions using heated blood and cyclosporine. Preservation of the transfusion effect in the absence of sensitization.
    Martinelli GP; Horowitz C; Chiang K; Racelis D; Schanzer H
    Transplantation; 1987 Jan; 43(1):140-5. PubMed ID: 3541314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Living-donor renal transplantation in SEOPF. The impact of histocompatibility, transfusions, and cyclosporine on outcome.
    Sanfilippo F; Thacker L; Vaughn WK
    Transplantation; 1990 Jan; 49(1):25-9. PubMed ID: 2301022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved renal allograft survival following donor-specific transfusions. II. In vitro correlates of early (DST-type) rejection episodes.
    Burlingham WJ; Grailer A; Sparks-Mackety EM; Sondel PM; Sollinger HW
    Transplantation; 1987 Jan; 43(1):41-6. PubMed ID: 2948309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of allograft survival by donor-specific transfusion one day prior to transplant. Importance of timing and specificity when DST is given with cyclosporine.
    Brunson ME; Tchervenkov JI; Alexander JW
    Transplantation; 1991 Sep; 52(3):545-9. PubMed ID: 1716800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor specific transfusions or cyclosporine for related-donor kidney transplantation?
    Jayes RL; Levey AS
    Kidney Int; 1989 Sep; 36(3):485-96. PubMed ID: 2593493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group.
    Alexander JW; Light JA; Donaldson LA; Delmonico FL; Diethelm AG; Wilkinson A; Rosenthal JT; Thistlethwaite JR; Hunsicker LG; Matas AJ; First MR; Reinsmoen NL; Rose SM
    Transplantation; 1999 Oct; 68(8):1117-24. PubMed ID: 10551639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-specific blood transfusions versus cyclosporine--the DST story.
    Salvatierra O; Melzer J; Vincenti F; Amend WJ; Tomlanovich S; Potter D; Husing R; Garovoy M; Feduska NJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):160-6. PubMed ID: 3547813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.